GL1X · GenesisL1 explorer

Research workbench

Structure of spin-labeled T4 lysozyme mutant T115R7

Analyse Structure of spin-labeled T4 lysozyme mutant T115R7 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2NTG
Type
protein
Length
164 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
P00720
Ligands
R7A
Pockets
1 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 64% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein16464% helix, 8% strandP00720

Ligands and binding sites

  • R7A · S-[(4-bromo-1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate · ligand · chains A
  • BME · Beta-mercaptoethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12280.530.7731empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 2NTG · Structure of Spin-labeled T4 Lysozyme Mutant T115R7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.